| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193614 | Annals of Allergy, Asthma & Immunology | 2006 | 5 Pages |
Abstract
These results confirm the lack of cross-reactivity between specific cyclooxygenase-2 inhibitors and aspirin in AERD. Etoricoxib was safe for treating inflammation in patients with AERD.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Yasser MD, Sally MSc, Ihab MRCP, Maha MD,